Αποτελέσματα Αναζήτησης
15 Αυγ 2022 · IR of major amputations was 94.82 (95% CI 56.62–158.80) per 100,000 individuals with diabetes, among patients with type 1 diabetes was 100.76 (95% CI 53.71–189.01) and among type 2 diabetes was 40.58 (95% CI 11.03–149.28).
25 Ιουν 2020 · The burden of amputation is severe, with 5-year mortality rates exceeding those of many malignancies. Furthermore, caring for patients with PAD and diabetes mellitus imposes a significant cost to the healthcare system—estimated to range from $84 billion to $380 billion annually.
16 Μαρ 2023 · In adults with diabetes, diabetic foot ulcer (DFU) and amputation are common and associated with significant morbidity and mortality. Identify tools predicting risk of DFU or amputation that are prognostically accurate and clinically feasible.
The AMPREDICT-Mortality prediction model is a validated parsimonious model that can be used to inform the 1-year mortality risk following non-traumatic lower extremity amputation of patients with peripheral artery disease or diabetes.
24 Αυγ 2020 · Along with high prevalence rates, the number of diabetic complications also increases , among them are diabetic foot ulceration (DFU) . Closely linked to the risk of lower extremity amputation, DFU causes imminent disease burden, high costs [11, 12] and high mortality rates [13–15].
21 Απρ 2023 · The influence of diabetes mellitus (DM) on mortality following lower extremity amputation (LEA) remains controversial. This systematic review and meta-analysis aimed to determine the influence of DM on long-term mortality (LTM) and short-term mortality (STM) after amputation.
Mortality after below-the-knee amputation ranged from 40% to 82% and after above-the-knee amputation from 40% to 90%. The risk factors for increased mortality included age, renal disease, proximal amputation, and peripheral vascular disease.
